ABVC BioPharma, Inc.
ABVC
$2.73
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -168.02% | -467.25% | 222.88% | 80.20% | 66.75% |
| Total Depreciation and Amortization | -29.06% | -36.48% | 2,461.43% | -93.88% | 11.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 693.83% | 130.45% | -301.27% | -23.39% | -79.09% |
| Change in Net Operating Assets | -1,795.85% | 91.25% | -1,850.79% | -92.78% | 151.51% |
| Cash from Operations | -65.65% | -9.36% | -387.48% | 181.22% | 77.88% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | 184.88% |
| Total Debt Repaid | -152.90% | 83.45% | 1.17% | -- | -- |
| Issuance of Common Stock | 395.21% | 439.58% | 126.41% | -74.27% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -200.00% | -- | -- | 100.00% | -135.62% |
| Cash from Financing | 349.46% | -26.26% | 499.93% | -118.13% | -13.19% |
| Foreign Exchange rate Adjustments | -844.12% | 11.48% | 662.50% | 114.81% | 79.31% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 404.03% | -210.97% | 246.49% | -67.66% | 244.98% |